Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis Matthew D. Vesely, MD, PhD, Suguru Imaeda, MD, Brett A. King, MD, PhD JAAD Case Reports Volume 3, Issue 1, Pages 4-6 (January 2017) DOI: 10.1016/j.jdcr.2016.09.008 Copyright © 2016 Terms and Conditions
Fig 1 CAD before and after treatment with tofacitinib. A and C, Before treatment with tofacitinib, there were edematous and lichenified pink-red and violaceous plaques photodistributed on the face, chest, and posterior neck, with sharp demarcation at the shirt collar. B and D, Marked improvement in the rash visible 10 months after starting tofacitinib (photographs taken during the spring). JAAD Case Reports 2017 3, 4-6DOI: (10.1016/j.jdcr.2016.09.008) Copyright © 2016 Terms and Conditions